Premium
Effects of phenobarbitone on serum biochemical tests in dogs
Author(s) -
FOSTER SF,
CHURCH DB,
WATSON ADJ
Publication year - 2000
Publication title -
australian veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.382
H-Index - 59
eISSN - 1751-0813
pISSN - 0005-0423
DOI - 10.1111/j.1751-0813.2000.tb10350.x
Subject(s) - alkaline phosphatase , albumin , bilirubin , phenobarbital , medicine , endocrinology , cholesterol , chemistry , serum albumin , gamma glutamyltransferase , alanine aminotransferase , enzyme , biochemistry , biology
Objectives To investigate effects of phenobarbitone on serum activities of alanine aminotransferase, alkaline phosphatase and gamma‐glutamyl transferase and concentrations of bilirubin, albumin, cholesterol and total protein in dogs. Animals Ten crossbreed experimental dogs and 10 client‐owned dogs of mixed breeds treated chronically with phenobarbitone to control seizures. Procedures Experimental dogs were allocated to treatment (6 mg/kg oral phenobarbitone, n = 6) and control (no treatment, n = 4) groups in which serum biochemical tests were performed at intervals during a 3‐month period. Biochemical tests were performed once on the 10 epileptic dogs. Results Phenobarbitone caused increased serum alkaline phosphatase activity but did not affect gammaglutamyl transferase activity or bilirubin, cholesterol, albumin and total protein concentrations. Phenobarbitone had minimal effect on alanine aminotransferase activity. Conclusions Individual dogs treated with phenobarbitone may have small increases in serum alanine aminotransferase activity and variable increases in alkaline phosphatase activity but are unlikely to have alterations in gamma‐glutamyl transferase activity or bilirubin, cholesterol, albumin or total protein concentrations.